You are here

  • Home
  • Archive
  • Volume 28, Issue 4
  • The incidence and risk of cutaneous toxicities associated with dabrafenib in melanoma patients: a systematic review and meta-analysis

Article metrics

Article menu

Download PDFPDF

Systematic review
The incidence and risk of cutaneous toxicities associated with dabrafenib in melanoma patients: a systematic review and meta-analysis

 

Online download statistics by month:

Online download statistics by month: September 2020 to November 2024

AbstractFullPdf
Sep 202060576
Oct 202026565
Nov 202013120
Dec 20206000
Jan 202111611
Feb 202110900
Mar 202110152
Apr 20219911
May 202110022
Jun 20211096
Jul 2021755
Aug 2021633
Sep 2021200
Oct 202120143
Nov 202119612
Dec 202113576
Jan 202212251
Feb 202215231
Mar 202220821
Apr 202219774
May 202218342
Jun 202217053
Jul 202213210
Aug 202214451
Sep 202215840
Oct 202215952
Nov 20228600
Dec 202210320
Jan 20236811
Feb 20237511
Mar 20236230
Apr 20239400
May 20237613
Jun 20235000
Jul 20236520
Aug 20237111
Sep 20233510
Oct 20237000
Nov 20234710
Dec 202310143
Jan 20248934
Feb 202413214
Mar 20248530
Apr 202412411
May 20249601
Jun 202410222
Jul 20248402
Aug 202418752
Sep 202413031
Oct 202413001
Nov 202410520
Total603513184